BerganKDV Wealth Management’s Biocept, Inc. BIOC Stock Holding History

BerganKDV Wealth Management’s Portfolio BIOC Stock Details BIOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-3	Closed	–	–	1028
2020 Q3	$0	Buy	+3	New	+$606	﹤0.01%	1032

Other funds holding BIOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

OQS

Occudo Quantitative Strategies Fort Lauderdale, Florida $1.84B AUM 22.15% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BerganKDV Wealth Management's BIOC Position: Q4 2020 in Review

BerganKDV Wealth Management sold out of Biocept, Inc. (BIOC) in Q4 2020, closing a stake of 3 shares.

BerganKDV Wealth Management first reported a position in BIOC in Q3 2020 and held it in 1 quarter. The position peaked at $0 in Q3 2020. 22 funds tracked by Wall St. Rank hold BIOC as of Q4 2020.

BerganKDV Wealth Management reported no remaining Biocept, Inc. position as of Q4 2020 after selling out during the quarter.
BerganKDV Wealth Management sold 3 Biocept, Inc. shares in Q4 2020.
BerganKDV Wealth Management first reported a position in Biocept, Inc. in Q3 2020 and held it in 1 quarter.
BerganKDV Wealth Management's Biocept, Inc. position peaked at $0 in Q3 2020.
22 funds tracked by Wall St. Rank held Biocept, Inc. as of Q4 2020.

Based on BerganKDV Wealth Management's 13F filing for Q4 2020, filed 4 Feb 2021.